DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE

Title:

DRUG FOR INHIBITING ADIPOSE CELL DIFFERENTIATION AND INSULIN RESISTANCE

Document Type and Number:

WIPO Patent Application WO/2016/070798

Kind Code:

A1

Abstract:

Provided in the present invention is a use of endostatin or a functional variant thereof in the preparation of a drug for treating alimentary obesity, non-alcoholic fatty liver disease, insulin resistance or glucose intolerance. In an embodiment of the invention, the functional variant can be YH-16, mES, mYH-16, m003, m007, mZ101, etc.

Inventors:

LUO YONGZHANG (CN)
WANG HUI (CN)
LI HUI (CN)
LU XINAN (CN)
FU YAN (CN)
ZHAN SHUNLI (CN)
ZHOU DAIFU (CN)

Application Number:

PCT/CN2015/093726

Publication Date:

May 12, 2016

Filing Date:

November 03, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV TSINGHUA (CN)
BEIJING PROTGEN LTD (CN)

International Classes:

A61K38/17; A61P1/16; A61P3/04; A61P5/50

Foreign References:

CN103703140A	2014-04-02
CN101596320A	2009-12-09

Other References: